Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155843 · ClinicalTrials.gov registry record
Neural Mechanisms in Asthma
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 31
- Enrollment target
NCT01155843: Completed study, sponsored by University of Wisconsin, Madison.
NCT01155843 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01155843 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Asthma is a chronic disease that affects nearly 13% of adults in the U.S., causing substantial impairment that is reflected in the tens of millions of missed days of work, and doctors' and emergency room visits it leads to annually. Those who have asthma are twice as likely to develop depression and anxiety, which are associated with more frequent and severe asthma symptoms, especially in those under chronic stress. The project proposed here seeks to understand the role of the brain in these associations and to evaluate the neural mechanisms through which a safe, low-cost intervention, that influences the function of body via the mind, may diminish the expression of asthma symptoms.
Primary Outcome
positron emission tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-11 |
What the finished NCT01155843 record still lists
NCT01155843 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01155843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01155843 about?
NCT01155843 is a clinical study titled "Neural Mechanisms in Asthma". Asthma is a chronic disease that affects nearly 13% of adults in the U.S., causing substantial impairment that is reflected in the tens of millions of missed days of work, and doctors' and emergency room visits it leads to annually. Those who have asthma are twice as likely to develop depression and...
What is the current status of trial NCT01155843?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2011-10. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT01155843?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia